Alexion Pharma International Trading, a subsidiary of the biopharmaceutical company Alexion Pharmaceuticals Inc.,  plans to expand its operations in Ireland following the acquisition of a new site in West Dublin, according to a press statement by IDA Ireland, Ireland’s agency responsible for overseas investment. The company expects that this expansion will create approximately 200 new jobs at Alexion as part of an investment of approximately EUR 75 million ($103 million) in this new site over the next two years.  In addition to the company jobs, up to 200 new construction jobs are also expected to be created as a result of this expansion.  

Alexion announced its decision to establish global supply chain and quality operations in Ireland in July 2013, and the company currently employs more than 60 people at its first site in Park West. In February 2014, Alexion announced plans to acquire a second site in Athlone to create an aseptic vial fill/finish facility. Alexion’s now has announced plans for a third site, the company's total job creation in Ireland is expected to rise to approximately 300 by 2016. Alexion has begun recruitment for the College Park posts to build on its existing workforce and capabilities in Ireland.

Alexion has been granted Planning Permission from Fingal County Council to construct a new 15,000-square meter laboratory, office, packaging and warehouse facility on a 41-acre greenfield site at College Park in Blanchardstown. The initial phase of the project will see the creation of approximately 200 new jobs by 2016 in supply chain, quality control, packaging, warehousing and supporting functions. 

Source: IDA Ireland